Table 2.
Characteristics of participants that indicated that their choice caused them harm on item-level analysis of the Decision Regret Scale
| Respondent type | Diagnostic subclass | Treatment status at discussion | Provider of discussion | Pubertal status at discussion | FP Modality | Recalls discussion | DR score | DR category | |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Patient | Liquid | Post high-risk treatment | Oncologist + oncofertility specialist | Post-pubertal | None | No | 95 | High |
| 2 | Parent | Liquid | Post high-risk treatment | Oncologist + oncofertility specialist | Post-pubertal | None | No | 95 | High |
| 3 | Parent | Solid | Pre high-risk treatment | Oncologist + oncofertility specialist | Pre-pubertal | TTCP | Yes | 30 | High |
| 4 | Parent | Liquid | Pre high-risk treatment | Oncologist + oncofertility specialist | Pre-pubertal | None | Yes | 30 | High |
| 5 | Parent | Solid | Pre high-risk treatment | Oncologist + oncofertility specialist | Pre-pubertal | OTCP | Yes | 15 | Low |
| 6 | Parent | Not cancer | Pre high-risk treatment | Oncologist + oncofertility specialist | Pre-pubertal | None | Yes | 15 | Low |
| 7 | Parent | Solid | Pre high-risk treatment | Oncologist + oncofertility specialist | Pre-pubertal | OTCP | Yes | 15 | Low |
| 8 | Patient | Solid | Pre high-risk treatment | Oncologist only | Post-pubertal | Sperm | Yes | 20 | Low |
OTCP, ovarian tissue cryopreservation; TTCP, testicular tissue cryopreservation; FP, fertility preservation; DR, decision regret